Company Valuation: Neolife

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023
Market Cap 1 6.866 23.36 16.13 3.687 6.929
Change - 240.27% -30.95% -77.14% 87.91%
Enterprise Value (EV) 1 7.143 23.31 17 4.341 7.35
Change - 226.3% -27.07% -74.46% 69.33%
P/E -8.1x -45.2x -95.3x -1.87x -13.2x
PBR 3.27x 10.9x 7.24x 1.41x 1.61x
PEG - 0.9x 1.4x -0x 0.2x
Capitalization / Revenue 0.79x 2.88x 1.46x 0.27x 0.52x
EV / Revenue 0.83x 2.87x 1.53x 0.32x 0.55x
EV / EBITDA -15.6x 68.8x 118x -4.85x 49.3x
EV / EBIT -11.3x -68.3x 1,953x -4.21x -13.9x
EV / FCF -18.3x 55.1x -15.6x -7.71x -
FCF Yield -5.47% 1.82% -6.41% -13% -
Dividend per Share 2 - - - - -
Rate of return - - - - -
EPS 2 -0.02 -0.01 -0.003233 -0.0376 -0.005432
Distribution rate - - - - -
Net sales 1 8.655 8.126 11.09 13.55 13.43
EBITDA 1 -0.4572 0.3389 0.1444 -0.8945 0.1491
EBIT 1 -0.6331 -0.3414 0.008702 -1.03 -0.5289
Net income 1 -0.9307 -0.5163 -0.1693 -3.625 -0.5235
Net Debt 1 0.2768 -0.0553 0.8645 0.6534 0.4211
Reference price 2 0.1620 0.4520 0.3080 0.0704 0.0719
Nbr of stocks (in thousands) 42,382 51,687 52,378 52,378 96,371
Announcement Date 6/25/20 4/5/22 4/5/22 4/28/23 4/29/24
1EUR in Million2EUR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 6.92M
14.61x1.76x8.47x1.85% 56.58B
31.13x5.83x17.23x0.71% 34.39B
33.42x3.46x17.74x0.92% 34.24B
27.31x4.33x14.46x0.85% 31.75B
11.43x1.38x6.41x2.69% 28.78B
22.08x6.87x13.53x1.97% 25.46B
72.99x4.55x70.45x0.31% 22.58B
15.52x1.95x7.83x1.41% 20.71B
10.1x1.11x5.43x1.02% 14.15B
Average 26.51x 3.47x 17.95x 1.3% 26.86B
Weighted average by Cap. 25.73x 3.46x 16.74x 1.36%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA